Literature DB >> 24865600

Screening for lung cancer using low dose computed tomography.

Martin C Tammemagi1, Stephen Lam2.   

Abstract

Screening for lung cancer with low dose computed tomography can reduce mortality from the disease by 20% in high risk smokers. This review covers the state of the art knowledge on several aspects of implementing a screening program. The most important are to identify people who are at high enough risk to warrant screening and the appropriate management of lung nodules found at screening. An accurate risk prediction model is more efficient than age and pack years of smoking alone at identifying those who will develop lung cancer and die from the disease. Algorithms are available for assessing people who screen positive to determine who needs additional imaging or invasive investigations. Concerns about low dose computed tomography screening include false positive results, overdiagnosis, radiation exposure, and costs. Further work is needed to define the frequency and duration of screening and to refine risk prediction models so that they can be used to assess the risk of lung cancer in special populations. Another important area is the use of computer vision software tools to facilitate high throughput interpretation of low dose computed tomography images so that costs can be reduced and the consistency of scan interpretation can be improved. Sufficient data are available to support the implementation of screening programs at the population level in stages that can be expanded when found to perform well to improve the outcome of patients with lung cancer. © BMJ Publishing Group Ltd 2014.

Entities:  

Mesh:

Year:  2014        PMID: 24865600     DOI: 10.1136/bmj.g2253

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  28 in total

Review 1.  Cancer Screening in the Elderly: A Review of Breast, Colorectal, Lung, and Prostate Cancer Screening.

Authors:  Ashwin A Kotwal; Mara A Schonberg
Journal:  Cancer J       Date:  2017 Jul/Aug       Impact factor: 3.360

2.  Characterization of Individuals Taking Part in Low Dose Computed Tomography (LDCT) Screening Program.

Authors:  Mariann Moizs; Gábor Bajzik; Zsuzsanna Lelovics; János Strausz; Marianna Rakvács; Péter Zádori; Árpád Kovács; Imre Repa
Journal:  Pathol Oncol Res       Date:  2015-05-25       Impact factor: 3.201

Review 3.  Screening for lung cancer using low-dose computed tomography: concerns about the application in low-risk individuals.

Authors:  Jiu-Wei Cui; Wei Li; Fu-Jun Han; Yu-Di Liu
Journal:  Transl Lung Cancer Res       Date:  2015-06

4.  Controlled settings for lung cancer screening: why do they matter? Considerations for referring clinicians.

Authors:  A Bharmal; A Crosskill; S Lam; H Bryant
Journal:  Curr Oncol       Date:  2016-12-21       Impact factor: 3.677

5.  Lung Cancer Risk Prediction Using Common SNPs Located in GWAS-Identified Susceptibility Regions.

Authors:  Joel L Weissfeld; Yan Lin; Hui-Min Lin; Brenda F Kurland; David O Wilson; Carl R Fuhrman; Arjun Pennathur; Marjorie Romkes; Tomoko Nukui; Jian-Min Yuan; Jill M Siegfried; Brenda Diergaarde
Journal:  J Thorac Oncol       Date:  2015-11       Impact factor: 15.609

6.  Early Detection of Lung Cancer with Meso Tetra (4-Carboxyphenyl) Porphyrin-Labeled Sputum.

Authors:  Lara Patriquin; Daniel T Merrick; David Hill; Richard G Holcomb; Madeleine E Lemieux; Gordon Bennett; Bijal Karia; Vivienne I Rebel; Thomas Bauer
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

7.  Lung cancer screening primer: Key information for primary care providers.

Authors:  Anna N Wilkinson; Stephen Lam
Journal:  Can Fam Physician       Date:  2021-11       Impact factor: 3.275

8. 

Authors:  Anna N Wilkinson; Stephen Lam
Journal:  Can Fam Physician       Date:  2021-11       Impact factor: 3.275

Review 9.  Risk factors assessment and risk prediction models in lung cancer screening candidates.

Authors:  Mariusz Adamek; Ewa Wachuła; Sylwia Szabłowska-Siwik; Agnieszka Boratyn-Nowicka; Damian Czyżewski
Journal:  Ann Transl Med       Date:  2016-04

10.  Lung cancer screening with low-dose spiral computed tomography: evidence from a pooled analysis of two Italian randomized trials.

Authors:  Maurizio Infante; Stefano Sestini; Carlotta Galeone; Alfonso Marchianò; Fabio R Lutman; Enzo Angeli; Giuseppina Calareso; Giuseppe Pelosi; Gabriella Sozzi; Mario Silva; Nicola Sverzellati; Silvio Cavuto; Carlo La Vecchia; Armando Santoro; Marco Alloisio; Ugo Pastorino
Journal:  Eur J Cancer Prev       Date:  2017-07       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.